Mutations in epigenetic regulators in myelodysplastic syndromes

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International journal of hematology

• Publication date

  2012-01-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12185-011-0996-3PMID 22234528
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recurrent DNMT3A R882 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

  2011cited by this paper
• Hypomethylating agents and other novel strategies in myelodysplastic syndromes.

  2011cited by this paper
• The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases

  2011cited by this paper
• Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.

  2011cited by this paper
• Clinical effect of point mutations in myelodysplastic syndromes.

  2011cited by this paper
• Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

  2011cited by this paper
• ICF syndrome mutations cause a broad spectrum of biochemical defects in DNMT3B-mediated de novo DNA methylation.

  2011cited by this paper
• Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia.

  2011cited by this paper
• Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

  2011cited by this paper
• Aberrations of EZH2 in Cancer

  2011cited by this paper
• Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA

  2011cited by this paper
• Frequent pathway mutations of splicing machinery in myelodysplasia

  2011cited by this paper
• Classification and prognostic evaluation of myelodysplastic syndromes.

  2011cited by this paper
• A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders

  2011cited by this paper
• Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes

  2011cited by this paper
• Characterization of DNA-binding activity in the N-terminal domain of the DNA methyltransferase Dnmt3a.

  2011cited by this paper
• TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.

  2011cited by this paper
• Heterochromatic Genes Undergo Epigenetic Changes and Escape Silencing in Immunodeficiency, Centromeric Instability, Facial Anomalies (ICF) Syndrome

  2011cited by this paper
• Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine

  2011cited by this paper
• Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.

  2011cited by this paper
• Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors

  2011cited by this paper
• Structure and Function of Mammalian DNA Methyltransferases

  2011cited by this paper
• Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.

  2011cited by this paper
• Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

  2011cited by this paper
• Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients

  2011cited by this paper
• Rare occurrence of DNMT3A mutations in myelodysplastic syndromes

  2011cited by this paper
• Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

  2010cited by this paper
• Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

  2010cited by this paper
• IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis

  2010cited by this paper
• Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

  2010cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2010cited by this paper
• Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

  2010cited by this paper
• Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome‐wide single nucleotide polymorphism array analysis

  2010cited by this paper
• Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

  2010cited by this paper
• Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.

  2010cited by this paper
• The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alteration

  2010cited by this paper
• Glioma-derived mutations in IDH: from mechanism to potential therapy.

  2010cited by this paper
• Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

  2010cited by this paper
• How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromes.

  2010cited by this paper
• IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia.

  2010cited by this paper
• Update on molecular findings, management and outcome in low-grade gliomas

  2010cited by this paper
• Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

  2010cited by this paper
• DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes.

  2010cited by this paper
• Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes

  2010cited by this paper
• Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

  2010cited by this paper
• Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

  2010cited by this paper
• Additional Sex Comb-like (ASXL) Proteins 1 and 2 Play Opposite Roles in Adipogenesis via Reciprocal Regulation of Peroxisome Proliferator-activated Receptor γ*

  2010cited by this paper
• Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q)

  2010cited by this paper
• Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

  2010cited by this paper
• Myelodysplastic syndromes.

  2009cited by this paper
• Mutation in TET2 in myeloid cancers.

  2009cited by this paper
• Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation.

  2009cited by this paper
• Acquired mutations in TET2 are common in myelodysplastic syndromes

  2009cited by this paper
• Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1

  2009cited by this paper
• Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia

  2009cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2009cited by this paper
• ASXL1 Represses Retinoic Acid Receptor-mediated Transcription through Associating with HP1 and LSD1*

  2009cited by this paper
• MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.

  2009cited by this paper
• Myelodysplastic syndromes.

  2008cited by this paper
• Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores

  2008cited by this paper
• Mammalian DNA methyltransferases: a structural perspective.

  2008cited by this paper
• De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells

  2007cited by this paper
• New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.

  2007cited by this paper
• Sex‐specific windows for high mRNA expression of DNA methyltransferases 1 and 3A and methyl‐CpG‐binding domain proteins 2 and 4 in human fetal gonads

  2007cited by this paper
• Additional Sex Comb-like 1 (ASXL1), in Cooperation with SRC-1, Acts as a Ligand-dependent Coactivator for Retinoic Acid Receptor*

  2006cited by this paper
• Unfinished symphony

  2006cited by this paper
• Expression of DNMT3A transcripts and nucleolar localization of DNMT3A protein in human testicular and fibroblast cells suggest a role for de novo DNA methylation in nucleolar inactivation

  2006cited by this paper
• Aberrant DNA methylation as a cancer-inducing mechanism.

  2005cited by this paper

• [Tatton-Brown-Rahman syndrome associated with the DNMT3A gene: a case report and literature review].

  2020influential citation
• heterozygous protein-truncating variants cause a recognizable syndrome with intellectual disability and distinctive facial gestalt : A study to clarify the HIST 1 H 1 E syndrome phenotype in 30 individuals

  2019cites this paper
• The roles of DNA, RNA and histone methylation in ageing and cancer

  2019cites this paper
• De novo variants in SETD1B are associated with intellectual disability, epilepsy and autism

  2018cites this paper
• Double sword role of EZH2 in leukemia.

  2018cites this paper
• Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine

  2018influential citation
• The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants

  2018cites this paper
• From cellular morphology to molecular and epigenetic anomalies of myelodysplastic syndromes

  2018cites this paper
• Novel DNMT3A germline mutations are associated with inherited Tatton‐Brown–Rahman syndrome

  2017cites this paper
• Comparison of the Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Glasgow Prognostic Score in Diffuse Large B-Cell Lymphoma

  2016cites this paper
• DNA Methylation and Adult Neurogenesis

  2016cites this paper
• Digging deep into “dirty” drugs – modulation of the methylation machinery

  2015cites this paper
• Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia

  2015cites this paper
• The myelodysplastic syndromes: the era of understanding

  2015cites this paper
• The molecular pathogenesis of the myelodysplastic syndromes

  2015cites this paper
• Functional characterization of a novel FGFR1OP‐RET rearrangement in hematopoietic malignancies

  2014cites this paper
• Mutations in the DNA methyltransferase gene, DNMT3A, cause an overgrowth syndrome with intellectual disability

  2014cites this paper
• The molecular basis of myeloid malignancies

  2014cites this paper
• Age-related epigenetic drift in the pathogenesis of MDS and AML

  2014cites this paper
• NSD1, EZH2 and DNMT3A Overgrowth Genes and Their Associated Overgrowth Syndromes

  2014cites this paper
• C-terminal-truncating ASXL1 mutations induce MDS via inhibition of PRC2

  2014cites this paper
• Review The molecular basis of myeloid malignancies

  2014cites this paper
• TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes.

  2013cites this paper
• Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.

  2013cites this paper
• A Personalized Molecular Pathogenesis of MDS

  2013cites this paper
• (Mll-PTD) hematopoietic stem/progenitor cells bias, and myeloid differentiation in Mll partial tandem duplication Stress hematopoiesis reveals abnormal control of self-renewal, lineage

  2013cites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  2013cites this paper
• Epigenetic aspects of MDS and its molecular targeted therapy

  2013influential citation
• Treatment of Myelodysplastic Syndrome and Acute Myeloid Leukemia by Immunomodulatory and Epigenetic Drugs

  2013cites this paper
• Detection of acquired hemoglobinopathy in children with hematological malignancies at disease onset: results form a national referral centre

  2013cites this paper
• [Application of DNA methyltransferase inhibitors for myelodysplastic syndrome].

  2013influential citation
• Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.

  2012cites this paper
• Spliceosome-related gene mutations in myelodysplastic syndrome can be used as stable markers for monitoring minimal residual disease during follow-up.

  2012cites this paper
• [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. pathogenesis and pathophysiology of bone-marrow failure; 3. Myelodysplastic syndrome].

  2012cites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper
• Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

  year unknowncites this paper